BIODLINK-B (01875) announced its financial results for 2025, achieving an operating revenue of approximately RMB 748 million. This represents a decrease of 31.93% compared to the previous year. The company reported a net loss of around RMB 100 million, a shift from profitability to loss year-on-year. Regarding its financial position, the total net assets stood at approximately RMB 626 million as of the end of 2025. Both current liabilities and non-current liabilities saw a decline compared to the prior year.